Results 81 to 90 of about 4,356 (97)
Some of the next articles are maybe not open access.

Systemic Effects of Timolol

JAMA: The Journal of the American Medical Association, 1980
To the Editor.— I read the letter from Stephen A. Shaivitz, MD (242:1612, 1979), inThe Journal, titled "Timolol and Myasthenia Gravis." I was involved in some of the early clinical evaluation of timolol maleate, 1 and we, like most investigators at the time, found few or no side effects.
openaire   +3 more sources

Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma

Expert Opinion on Pharmacotherapy, 2010
The emergence of fixed-combination drugs for the treatment of glaucoma has, to some extent, changed the medical management of glaucoma. The potential benefits of these drugs include a reduction in the total number of drops and preservatives instilled per day and improved patient comfort factors, which may contribute to better compliance.
Andrea K Sawchyn   +2 more
openaire   +3 more sources

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate

American Journal of Ophthalmology, 2000
We evaluated the anterior segment surface reaction findings between timolol hemihydrate and timolol maleate. The only known difference between these preparations is the maleate salt.After a baseline examination, we randomized 28 healthy subjects (26 completed) to timolol hemihydrate or timolol maleate given in both eyes twice daily, in a double masked ...
Jeanette A. Stewart   +3 more
openaire   +2 more sources

Topical Timolol for a Refractory Wound

Dermatologic Surgery, 2012
A43-year-old woman presented with a large refractory wound on her left mid-back (Figure 1A). Her past medical history was significant for a heart transplant in 1994 because of postpartum cardiomyopathy. Chronic rejection and subsequent worsening congestive heart failure resulted in a second heart transplant in 2008. A prolonged hospital stay, including
Jennifer C. Tang   +2 more
openaire   +3 more sources

Review Timolol Hemihydrate: A New Formulation of Timolol for the Treatment of Glaucoma

Journal of Ocular Pharmacology and Therapeutics, 1996
Timolol maleate, a non-selective beta-adrenergic blocker, has been used to treat glaucoma and ocular hypertension for almost two decades. Recently a new preparation, timolol hemihydrate, has been described which eliminates the maleate buffer and simplifies the purification step for the R-enantiomer.
openaire   +3 more sources

Electrophysiologic effects of intravenous timolol

International Journal of Cardiology, 1983
We evaluated the electrophysiologic effects and dose response of the long-acting beta-blocking drug timolol given intravenously to 12 patients during intracardiac electrophysiologic study. Electrophysiologic parameters were measured during control and immediately, 30 minutes, and 48 hours following infusion.
Marilyn D. Ezri   +4 more
openaire   +3 more sources

Concentration of timolol in aqueous humour

Documenta Ophthalmologica, 1991
Two groups of twenty patients who were to undergo a routine e.c.c.e. applied eye-drops containing timolol 0.1% or 0.5% twice daily during the week preceding their operation. A third group of twenty patients, using placebo drops, served as control. During the cataract surgery a sample of aqueous was collected.
openaire   +3 more sources

Langzeitresultate mit Timolol

Klinische Monatsblätter für Augenheilkunde, 1980
The results of an 18-month study with Timolol in 36 patients with glaucoma or ocular hypertension are presented. Patients with ocular hypertension were well controlled with Timolol alone, while in the glaucoma group most patients needed combined treatment with a parasympathomimetic drug.
openaire   +2 more sources

Atenolol and Timolol

New England Journal of Medicine, 1982
George T. Griffing   +13 more
openaire   +2 more sources

Respiratory Effects of Timolol

New England Journal of Medicine, 1984
F. T. Fraunfelder, Alan F. Barker
openaire   +3 more sources

Home - About - Disclaimer - Privacy